Taizhou Baiying Biotechnology
PrivateLast Round
Series B
Sep 2, 2022
Total Funding Raised
$92.05M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biointron is a biotechnology company specializing in recombinant antibody technology and contract research organization (CRO) services aimed at streamlining the antibody discovery process through advanced expression platforms, sequencing, and labeling tools.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Taizhou Baiying Biotechnology Comparables
Compare Taizhou Baiying Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biolabs | 85% | |
| Genovac Antibody Discovery | 82% | |
| ProteoGenix | 82% | |
Taizhou Baiying Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2022 | ||||
| Series A | May 24, 2021 | ||||
| Angel | Jul 23, 2018 |
Taizhou Baiying Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Haitong Bank | Series B |
| Joy Capital | Series B |
| Jiangsu Provincial Government Investment Fund | Series B |
| Furong Investment | Series A |
| ALAN Asset Management | Series B |
| Jiangsu Tianyou Investment Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
New platform helps drug developers identify manufacturing problems early.
- Dec 17, 2025
Received the 2025 Scientist.com Supplier Performance Recognition Award.
Taizhou Baiying Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Taizhou Baiying Biotechnology's valuation, stock price, and market status.